APA (7th ed.) Citation

LD, H., F, R., L, X., E, D., N, H., PR, S., . . . AG, T. (2015). Broad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling. Antimicrobial agents and chemotherapy, 59(2), 1052. https://doi.org/10.1128/AAC.04433-14

Chicago Style (17th ed.) Citation

LD, Hernandez, Racine F, Xiao L, DiNunzio E, Hairston N, Sheth PR, Murgolo NJ, and Therien AG. "Broad Coverage of Genetically Diverse Strains of Clostridium Difficile by Actoxumab and Bezlotoxumab Predicted by in Vitro Neutralization and Epitope Modeling." Antimicrobial Agents and Chemotherapy 59, no. 2 (2015): 1052. https://doi.org/10.1128/AAC.04433-14.

MLA (9th ed.) Citation

LD, Hernandez, et al. "Broad Coverage of Genetically Diverse Strains of Clostridium Difficile by Actoxumab and Bezlotoxumab Predicted by in Vitro Neutralization and Epitope Modeling." Antimicrobial Agents and Chemotherapy, vol. 59, no. 2, 2015, p. 1052, https://doi.org/10.1128/AAC.04433-14.